Study: Drug Combos Best for Heart Disease
Posted on: Thursday, 5 May 2005, 21:00 CDT
A British study finds that heart disease patients who take a combination of three drugs are more likely to survive than those taking a single drug.
The report in the British Medical Journal is the first survey to examine survival rates for coronary disease patients taking different drug combinations.
Researchers from the University of Nottingham tracked 13,000 patients diagnosed with ischaemic heart disease between 1996 and 2003.
The study found an 83 percent reduction in deaths among patients who took a combination of statins (cholesterol lowering drugs), aspirin and beta-blockers (a type of blood pressure lowering drug). Adding an angiotensin converting enzyme inhibitor, another blood-pressure-reduction drug, provided no additional benefit.
Taking beta-blockers alone reduced deaths by 19 percent, and angiotensin converting enzyme inhibitors alone by 20 percent.
The authors say that the study shows that a combination of beta-blockers, statins, aspirin and folic acid in a single pill, nicknamed the polypill, would benefit patients with heart disease.
Source: United Press International
Related Articles
- Coronary heart disease drops 31 percent
- A Weight Neutral Oral Antidiabetic Drug Would Earn a 25 Percent Patient Share in the Type 2 Diabetes Drug Market
- ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke
- Lipitor Provided an Unexpectedly Potent Heart Benefit in Patients With Chronic Stable Angina, According to New Study
- Abbott Enrolls First Patient in World's First Clinical Trial Designed to Study Drug Eluting Stent Treatment in Women
- In-hospital beta-blocker aids heart failure
- Psychiatric Drugs Fare Favorably When Companies Pay for Studies
- Statins, Beta-Blockers Lessen Heart Attack Risk, Says Stanford-Kaiser Study
- Heart drug for US blacks can cut costs: study
- Heart Disease Fails to Respond to Antibiotics, Study Finds
 |
 |
User Comments (0)
RSS Feeds